About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
ImmtGt(AW0256)Wtsi
gene trap AW0256, Wellcome Trust Sanger Institute
MGI:3857179
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
ImmtGt(AW0256)Wtsi/ImmtGt(AW0256)Wtsi involves: 129P2/OlaHsd MGI:7580846
ht2
ImmtGt(AW0256)Wtsi/Immt+ involves: 129P2/OlaHsd MGI:7580847


Genotype
MGI:7580846
hm1
Allelic
Composition
ImmtGt(AW0256)Wtsi/ImmtGt(AW0256)Wtsi
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ImmtGt(AW0256)Wtsi mutation (0 available); any Immt mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no viable homozygotes are recovered from E10.5 on

embryo
• embryos exhibit massive apoptosis at E9.5
• at E9.5, embryos show no clear shape
• at E7.5, embryos are much smaller than wild-type controls

growth/size/body
• at E7.5, embryos are much smaller than wild-type controls

cellular
• embryos exhibit massive apoptosis at E9.5




Genotype
MGI:7580847
ht2
Allelic
Composition
ImmtGt(AW0256)Wtsi/Immt+
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
ImmtGt(AW0256)Wtsi mutation (0 available); any Immt mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• in the Morris water maze test, mice show impaired ability to locate the platform after training, as indicated by an increase in distance, latency and mean annulus crossing at 12 months of age
• however, grip strength and velocity are relatively normal
• mice exhibit progressive neurological/motor dysfunction as early as 6 months of age
• however, mice are born in normal Mendelian ratios and show no apparent phenotype at birth
• mice show an increase in the time to cross a balance beam and a higher number of hindfeet missteps at 3 and 6 months of age, indicating poor motor balance and coordination
• treatment with antioxidant N-acetylcysteine (NAC) for 1 year restores the time to cross and the number of hindfeet missteps to wild-type values
• mice exhibit gait abnormalities with shorter stride length but increased hind base and matching at 6 and 12 months of age

nervous system
• cerebellar neurons exhibit abnormal mitochondrial morphology, with less condensed mitochondria matrix, vacuolation, and partial loss of mitochondrial cristae at 12 months of age
• treatment with antioxidant N-acetylcysteine (NAC) restores mitochondrial ultrastructure in cerebellar neurons
• following exposure to X-ray irradiation at P7, cerebellar neurons show increased cell apoptosis relative to similarly treated wild-type cells
• mice show partial enlargement of the lateral ventricles
• mice show a significant reduction in hippocampus volume
• mice with overt neurologic defects show a significant loss of cerebellar Purkinje cells at 12 months of age
• mice show a trend towards decreased cerebellum volume
• mice with overt neurologic defects show increased numbers of neurofibrillary tangles in the hippocampus, suggesting neurodegenerative changes
• mice with overt neurologic defects show a marked reduction of dopaminergic neurons in the substantia nigra

cellular
• cerebellar neurons exhibit partial loss of mitochondrial cristae at 12 months of age
• cerebellar neurons exhibit less condensed mitochondria matrix at 12 months of age
• mice exhibit an increased density of mitochondria in muscle with relatively normal mitochondrial structure at 2 and 10 months of age
• cerebellar neurons exhibit abnormal mitochondrial morphology, with less condensed mitochondria matrix, vacuolation, and partial loss of mitochondrial cristae at 12 months of age
• treatment with antioxidant N-acetylcysteine (NAC) restores mitochondrial ultrastructure in cerebellar neurons
• following exposure to X-ray irradiation at P7, mice show markedly increased DNA damage response markers (phosphorylated 53BP1 and SMC1 foci formation) in the external granule cell layer (EGL) of proliferating cerebella and increased cell apoptosis in cerebellar neurons relative to similarly treated wild-type controls
• following exposure to X-ray irradiation at P7, cerebellar neurons show increased cell apoptosis relative to similarly treated wild-type cells
• mice show a significantly higher level of 18F-fluorodeoxyglucose (18F-FDG) uptake in brain, suggesting increased glucose transport in the neurons
• cerebella neurons show a significant reduction in mitochondrial membrane potentials, suggesting impaired mitochondrial function
• NAC-treated mitochondria from cerebellar neurons exhibit an elevated O2 consumption and mitochondrial membrane potential at 10 months of age
• cerebellar neurons exhibit alterations in mitochondrial oxidative phosphorylation complexes in an age-dependent manner
• respiratory control ratio (RCR) measured by mitochondrial state 3 (R3)/state 4 (R4) is significantly lower than in wild-type controls
• however, mtDNA copy number is normal at 2 and 10 months of age
• aging mice exhibit significantly impaired OXPHOS function and ATP generation in brain
• cerebellar neurons exhibit increased reactive oxygen species (ROS) from 3 to 24 months of age
• active endogenous oxidative stress is detected in cerebellar DNA and protein by 8-OHdG and nitrotyrosine staining, respectively, at 14 months of age
• treatment with antioxidant N-acetylcysteine (NAC) reduces ROS levels in P7 cerebellar mitochondria to levels seen in untreated wild-type controls

homeostasis/metabolism
• mice exhibit significantly higher serum glucose levels at 2 and 10 months of age
• treatment with antioxidant NAC for 1 year restores serum glucose levels
• mice exhibit significantly higher serum lactate levels at 2 and 10 months of age
• treatment with antioxidant NAC for 1 year restores serum lactate levels
• mice exhibit higher serum creatine phosphate kinase (CPK) levels at 2 and 10 months of age
• treatment with antioxidant NAC for 1 year reduces serum CPK levels
• mice exhibit significantly higher serum lactate dehydrogenase (LDH) levels at 2 and 10 months of age
• treatment with antioxidant NAC for 1 year reduces serum LDH levels
• mice show significantly lower CO2 production (VCO2) than age-matched wild-type controls at >12 months of age
• mice show significantly higher CO2 production (VCO2) than age-matched wild-type controls at 2 and 10 months of age
• NAC treatment reduces but does not restore CO2 production to wild-type levels
• mice with apparent neurologic defects show significantly lower O2 consumption (VO2) than age-matched wild-type controls at >12 months of age
• mice without apparent neurologic defects show significantly higher O2 consumption (VO2) than age-matched wild-type controls at 2 and 10 months of age
• NAC treatment reduces but does not restore O2 consumption to wild-type levels
• mice show a significantly lower RER (VCO2/VO2) than age-matched wild-type controls at >12 months of age
• mice show a significantly higher RER (VCO2/VO2) than age-matched wild-type controls at 2 months of age
• mice exhibit elevated anaerobic glycolysis to compensate for disturbed energy metabolism

muscle
• mice exhibit an increased density of mitochondria in muscle with relatively normal mitochondrial structure at 2 and 10 months of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory